Most just lately, it's been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in similar places as classical opioid receptors, it binds to a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger and would not activate a 2nd